The one problem that every medical researcher and scientist in the 21st Century wants to solve is the treatment of cancer and increasing longevity among the human race. This is the reason why scientists and all other stakeholders in the field of medicine have intensified their research into the different therapies and treatments that are available for cancer. The past few decades have seen focus shift and land on the role that stem cells can play towards the treatment of cancer and slowing down of the aging process. This is precisely what Mikhail Blagosklonny, a professor of oncology at the Roswell Park Cancer Institute in New York has been studying.
Mikhail Blagosklonny started his journey as a medical scholar and researcher in Russia. He attended The First Pavlov State Medical University and acquired his MD there. He followed this up by getting his PhD in Cardiology from the same institute. After graduating, he was appointed to the post of associate professor at the New York Medical College. He worked here for a few years before he decided to join the Ordway Research Institute in Albany New York. It is in 20008 that he got his appointment as a researcher at the Roswell Park Cancer Institute, a position that he is still holding up to date. He has been researching on the causes of the cancer menace and the different therapies that can be used to offer protection to the normal cells from the damaging effects that come from cancer.
He is a supporter of the theory that TOR signaling is an efficient way to reduce the effects of cancer and aging. One of the popular anti-cancer drugs, Rampamycin can be used to lengthen the lives of patients according to him. He is actually very passionate about the use of the drug in cancer therapy. He has also published many articles and made contributions to medical journals about the same topics. He edits the Cell Cycle and Oncotarget magazines. He is a member of the board of editors for Cell Death and Differentiation. His life goal is to have human life extended through the use of the correct and effective therapies and treatments. View his LinkedIn profile.
If there is a dental service firm that is dominating this industry far and wide is MB2 Dental Solutions. MB2 Dental Solutions is a leading dental service company that operates as a partner to the affiliated dentists and practice owners all over the world. They also provide affiliated offices as well as an assortment of services to assist them to run their operations efficiently without having to give up the control of patient health care and standards of service at their practice. MB2 Dental Solutions affiliated dental offices enjoy 100% clinical autonomy and with the help of the MB2 team and are efficiently running every aspect of the practice.
How It Started
The founder and CEO of MB2 Dental Solutions, Chris Steven Villanueva started out like any other dentist in the service to the dental community. After becoming frustrated by the problems in both the Private Practice as well as Group Practice systems of dentistry, Dr. Villanueva started the MB2 Dental Solutions. Villanueva wanted dentists to be able to get back to enjoy their career and still reap the benefits as well as the profitability of this clinical talents and drive.
In short, the MB2 Dental Solutions was founded with the sole vision of combining the positive aspects of private practitioners and group practices while alleviating the negative characteristics of each one of them. Since its inception in the year 2009, MB2 has moved from vision to reality with more than 70 staff members and over 60 affiliated dental clinics.
MB2 Dental Solutions has seen incredible growth from their young history as a leading Dental Service Organization. After being founded by Dr. Chris Villanueva in the year 2009, MB2 has grown in rips and bounds to over six states in the US. By providing affiliated clinics a vast variety of services, MB2 enables doctors to run their practice proficiently without having to forfeit the control of patient care and standards of the service.
The Priority Dental system for MB2 Dental Solutions trademark, identity guidelines as well as the tagline is, ”Make Your Oral Health A Priority Now; You’ll Be Glad You Did.” The CDI Group initiated its partnership with the MB2 in 2014 by designing as well as implementing the Priority Dental Plan. Working very closely with senior the management at MB2, they created a dental plan that suits the MB2 brand as well as its affiliated services. The CDI Group also initiated the plan marketing materials such as plan brochures, posters, postcards and tabletop displays.
When Mark Stratton, 12, started having mild abdominal pains after meals, his mother, Julie, wanted to give it a while to see if it would resolve on its own. Julie was worried that another trip to the doctor’s office could mean huge medical bills that she couldn’t pay. But after the pain persisted for two weeks, it was clear they needed to see a doctor.
They were directed to Dell Children’s Medical Center. After waiting for what seemed like an eternity, the doctor emerged with the news no parent wants to hear – Mark had a rare form of pancreatic cancer called islet cell carcinoma. “At first I was devastated”, she said. “But the doctor quickly reassured us that this was a highly treatable form of cancer”. But Mark would need to undergo a major operation, referred to as the Whipple procedure. “The thing I worried most about was the pain. They had to open him up, god I didn’t want to think about that”, she says, holding back tears.
Luckily, Julie was connected with a team of anesthesiologists from the Capitol Anesthesiologist Association. They assured her that with a professional team carefully administering the agent Propofol, that Mark would be unaware of anything during the operation.
The operation was a huge success.
“I was really scared”, said Mark. But when asked if he was in a lot of pain, he said, “yeah, but mostly when I got home and didn’t take my pain meds”.
Today Mark is cancer free and both he and Julie are grateful for the expert services of the Capitol Anesthesiology Association.